Title : A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.

Pub. Date : 2019 Apr

PMID : 30771737






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After PCI, patients were randomized to trimetazidine (35 mg bid) or placebo on top of standard-of-care including event prevention drugs and antianginal treatment. Trimetazidine BH3 interacting domain death agonist Homo sapiens